The Selective Class I PI3K Inhibitor CH5132799 Targets Human Cancers Harboring Oncogenic PIK3CA Mutations
暂无分享，去创建一个
Miyuki Yoshida | N. Ishii | Y. Aoki | O. Kondoh | Shino Kuramoto | Y. Yoshimura | H. Ebiike | H. Tanimura | J. Ohwada | T. Yamazaki | Yukako Tachibana | Hiroshi Tanaka | T. Fujii | K. Sakata | K. Morita | Kiyoaki Sakata